CXCL5 stimulation of RANK ligand expression in Paget’s disease of bone

CXCL5 Promotes Prostate Cancer Progression

(2015) Lesa A Begley et al.   NEOPLASIA

CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor–bone microenvironment

(2012) Y Sambandam et al.   ONCOGENE

Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer

(2011) Aihua Li et al.   AMERICAN JOURNAL OF PATHOLOGY

Neutrophil Transintestinal Epithelial Migration to CXCR2 Ligands Is Regulated by Adenosine

(2011) Andrew W. Stadnyk et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

The RANKL Distal Control Region Is Required for the Increase in RANKL Expression, But Not the Bone Loss, Associated with Hyperparathyroidism or Lactation in Adult Mice

(2011) Melda Onal et al.   MOLECULAR ENDOCRINOLOGY

CREB Downregulation in Vascular Disease

(2010) Irene E. Schauer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

PCR detection of cytokines in normal human and pagetic osteoblast-like cells

(2010) M.A. Birch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

CXC Chemokine Ligand 2 Induced by Receptor Activator of NF- B Ligand Enhances Osteoclastogenesis

(2010) J. Ha et al.   JOURNAL OF IMMUNOLOGY

FGF-2 Stimulation of RANK Ligand Expression in Paget’s Disease of Bone

(2009) Kumaran Sundaram et al.   MOLECULAR ENDOCRINOLOGY

Cyclic AMP-Responsive Element Binding Protein- and Nuclear Factor- B-Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis

(2008) H. Sun et al.   Cancer Prevention Research

DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells

(2007) Kumaran Sundaram et al.   JOURNAL OF CELLULAR BIOCHEMISTRY